|
Volumn 7, Issue 4, 2001, Pages 350-352
|
Challenges for clinical trials on progressive multifocal leukoencephalopathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
CD4 ANTIGEN;
CIDOFOVIR;
CYTARABINE;
TOPOTECAN;
VIRUS DNA;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIBIOTIC THERAPY;
ARTICLE;
BRAIN BIOPSY;
CEREBROSPINAL FLUID;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DISEASE MARKER;
DRUG EFFICACY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE STATUS;
JC VIRUS;
METHODOLOGY;
PRIORITY JOURNAL;
PROGNOSIS;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
WHITE MATTER;
ANTIVIRAL AGENTS;
CLINICAL TRIALS;
HUMANS;
LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;
|
EID: 0034824289
PISSN: 13550284
EISSN: None
Source Type: Journal
DOI: 10.1080/13550280152537229 Document Type: Article |
Times cited : (2)
|
References (9)
|